|
ArthritisCentral News and Views|ArthritisCentral News and Views #42 -- 04/27/06 Episode
The Role of Calcium and Vitamin D in Postmenopausal Women
A report from the Women's Health Initiative has evaluated whether supplemental calcium and vitamin D provide any significant benefit in osteoporosis treatment.
The study investigated whether the supplements provided any significant protection against future bone fractures.
The study has a number of design flaws, which are pointed out. These include the fact that the control group was allowed to take calcium and vitamin D on their own along with hormonal therapy, bisphosphonates, and miacalcin.
Scientists question whether the vitamin D dose of 400 I.U.s per day used in this study is really sufficient for women.
Compliance in taking the calcium carbonate and vitamin D prescribed in this study was associated with a decreased rate of hip fracture, but unfortunately in those patients who failed to comply the benefits were not seen.
The study re-emphasizes the need to be evaluated with bone mineral density measurements (DEXA scan) to see if you are truly osteoporotic. Taking calcium and vitamin D does not substitute for a proper evaluation by your physician for the presence of osteoporosis.
Calcium and vitamin D are considered important background medications, but osteoporosis needs to be treated with more specific and stronger therapies including bisphosphonates (Fosamax, Actonel, Boniva), Forteo, Miacalcin nasal spray, or Evista.
[ Thu, 27 Apr 2006 07:56:04 -0500 ]
|